News

Massachusetts can lead in AI by merging machine, natural and human intelligence. Noubar Afeyan highlights the state's unique ...
Mark Hartley reveals the three most popular FTSE 100 shares found in Stocks and Shares ISAs — and why so many ISA ...
Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
Dr. Philip Dormitzer, former global head of vaccine research and development at Pfizer, has been subpoenaed by the House Judiciary Committee as it investigates Pfizer’s alleged delay in the release of ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
GSK has a lower P/E than the aggregate P/E of 27.89 of the Pharmaceuticals industry. Ideally, one might believe that the ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...
GSK PLC closed 15.86% short of its 52-week high of £16.79, which the company achieved on September 9th.
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...